Yahoo
– Company generated quarterly sequential growth with Q1 YCANTH® dispensed applicator units rising above 10,000 for the first time in a quarter – – As YCANTH distributor inventory levels have normalized, Company expects that dispensed applicator units will now more closely track demand and gross revenue – WEST CHESTER, Pa., April 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin
Yahoo
WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Gavin Corcoran, M.D. to its Board of Directors. “We are pleased to welcome Dr. Gavin Corcoran to our Board of Directors,” said Jayson Rieger, Ph.D., MBA, President and Chief Executive Officer of Verrica Pharmaceuticals. “Gavin i
Yahoo
Verrica Pharmaceuticals (VRCA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Yahoo
WEST CHESTER, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. 24th Annual Needham Virtual Healthcare Conference, April
Yahoo
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the appointment of Noah L. Rosenberg, M.D., as Chief Medical Officer. “We are excited to welcome Noah Rosenberg to the Verrica team as our new Chief Medical Officer,” said Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica.
Yahoo
Q4 2024 Verrica Pharmaceuticals Inc Earnings Call
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FATE | 30.34% | $152.42M | -69.07% | 0.00% |
PBYI | 29.52% | $150.32M | -37.27% | 0.00% |
MQ | 28.06% | $1.97B | -29.22% | 0.00% |
EVGO | 26.35% | $339.15M | +47.67% | 0.00% |
STTK | 26.31% | $40.78M | -91.40% | 0.00% |
ALLO | 25.53% | $349.80M | -47.04% | 0.00% |
JELD | 24.56% | $437.07M | -72.77% | 0.00% |
CRSP | 24.31% | $3.32B | -30.75% | 0.00% |
COGT | 23.77% | $508.91M | -31.65% | 0.00% |
HDSN | 23.45% | $233.77M | -50.09% | 0.00% |
TWST | 23.16% | $2.24B | +22.34% | 0.00% |
KALV | 21.90% | $618.96M | +20.29% | 0.00% |
GPRO | 21.32% | $85.42M | -69.34% | 0.00% |
AMC | 21.31% | $1.17B | -17.38% | 0.00% |
ABCL | 21.22% | $753.91M | -35.13% | 0.00% |
DMRC | 20.48% | $266.33M | -44.40% | 0.00% |
IMNM | 20.47% | $739.08M | -40.43% | 0.00% |
BEAM | 20.20% | $1.98B | -12.62% | 0.00% |
SDGR | 20.15% | $1.86B | +5.91% | 0.00% |
NATR | 20.15% | $209.60M | -41.91% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IX | <0.01% | $21.88B | -3.51% | 10.19% |
GRVY | -<0.01% | $405.89M | -13.91% | 0.00% |
OGS | <0.01% | $4.71B | +21.04% | 3.35% |
PRVA | -0.01% | $2.84B | +28.73% | 0.00% |
MTA | -0.01% | $289.51M | +3.30% | 0.00% |
RXT | -0.01% | $327.48M | -15.34% | 0.00% |
CAAP | 0.01% | $3.02B | +12.76% | 0.00% |
AIFU | -0.02% | $7.26M | -96.39% | 0.00% |
IBN | 0.02% | $118.49B | +27.03% | 0.71% |
EW | -0.02% | $41.27B | -20.48% | 0.00% |
DRI | 0.02% | $23.61B | +28.84% | 2.73% |
R | -0.03% | $5.65B | +10.74% | 2.23% |
OMF | 0.03% | $5.56B | -9.18% | 8.57% |
CFR | -0.04% | $7.38B | -1.76% | 3.21% |
RCL | -0.04% | $55.84B | +51.76% | 0.80% |
IT | 0.04% | $31.32B | -9.88% | 0.00% |
PJT | 0.04% | $3.09B | +38.33% | 0.74% |
ENR | -0.05% | $1.95B | -6.06% | 4.37% |
EVER | 0.05% | $813.44M | +16.71% | 0.00% |
VRT | -0.05% | $29.70B | -7.77% | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CORN | -0.01% | $53.39M | 0.2% |
USXF | 0.01% | $1.15B | 0.1% |
ROBO | -0.03% | $843.08M | 0.95% |
RING | 0.04% | $1.50B | 0.39% |
KBWY | -0.04% | $200.11M | 0.35% |
FHLC | -0.05% | $2.44B | 0.084% |
SHYD | 0.05% | $314.81M | 0.35% |
JVAL | -0.05% | $456.28M | 0.12% |
SPGP | 0.06% | $2.70B | 0.36% |
IGM | -0.08% | $4.74B | 0.41% |
IPO | 0.08% | $115.98M | 0.6% |
PCY | -0.09% | $1.16B | 0.5% |
FCTR | -0.10% | $56.71M | 0.65% |
USIG | -0.10% | $12.55B | 0.04% |
IHF | -0.13% | $605.76M | 0.4% |
PGF | -0.13% | $774.21M | 0.54% |
FRDM | 0.14% | $950.30M | 0.49% |
EMHY | -0.14% | $425.85M | 0.5% |
IBDR | -0.15% | $3.23B | 0.1% |
SPLB | -0.15% | $1.12B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FLBL | -22.84% | $1.03B | 0.45% |
CLOZ | -22.72% | $640.09M | 0.5% |
VPC | -19.16% | $52.44M | 9.72% |
CSHI | -18.18% | $494.34M | 0.38% |
VRIG | -17.80% | $1.29B | 0.3% |
MNA | -17.16% | $234.23M | 0.77% |
CLOA | -17.11% | $782.46M | 0.2% |
IAK | -16.86% | $704.51M | 0.39% |
EWS | -16.14% | $629.39M | 0.5% |
SEIX | -16.04% | $302.02M | 0.57% |
SRLN | -15.69% | $6.35B | 0.7% |
THTA | -15.20% | $35.12M | 0.49% |
BKLN | -14.90% | $5.90B | 0.65% |
YLD | -14.87% | $290.31M | 0.39% |
FLTR | -14.81% | $2.32B | 0.14% |
BIZD | -14.73% | $1.38B | 13.33% |
ACWV | -14.46% | $3.29B | 0.2% |
FLOT | -14.40% | $8.81B | 0.15% |
HYZD | -14.13% | $170.23M | 0.43% |
CNYA | -13.95% | $211.73M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ETH | 26.60% | $1.29B | 0% |
ETHW | 26.58% | $155.60M | 0% |
BTC | 26.47% | $3.28B | 0.15% |
ETHV | 26.40% | $73.36M | 0% |
FETH | 26.38% | $572.96M | 0.25% |
CETH | 26.38% | $10.40M | 0% |
QETH | 26.24% | $11.83M | 0.25% |
ETHA | 26.24% | $1.86B | 0.25% |
EZET | 26.13% | $18.55M | 0% |
CPSJ | 25.37% | $31.92M | 0.69% |
ARKG | 22.59% | $883.87M | 0.75% |
CPRJ | 19.38% | $47.37M | 0.69% |
QQA | 17.08% | $189.78M | 0.29% |
PBW | 16.93% | $180.80M | 0.65% |
XBI | 16.72% | $4.69B | 0.35% |
PTH | 16.28% | $99.66M | 0.6% |
GNOM | 15.29% | $47.90M | 0.5% |
HEAL | 14.86% | $34.93M | 0.68% |
XPH | 14.19% | $137.09M | 0.35% |
ICSH | 14.13% | $5.95B | 0.08% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INGR | -30.93% | $8.37B | +13.14% | 2.41% |
PGR | -26.28% | $155.37B | +24.90% | 1.84% |
ALL | -22.42% | $51.63B | +13.04% | 1.92% |
PFLT | -22.41% | - | - | 12.46% |
ACGL | -21.31% | $34.76B | +4.40% | 0.00% |
WTW | -20.76% | $32.37B | +23.14% | 1.08% |
HCKT | -20.61% | $705.55M | +14.29% | 1.74% |
VMEO | -18.78% | $827.56M | +42.41% | 0.00% |
CNA | -18.69% | $13.04B | +13.78% | 3.67% |
EIG | -18.36% | $1.18B | +8.04% | 2.47% |
PNNT | -17.68% | - | - | 14.89% |
SCM | -17.38% | - | - | 12.15% |
ARIS | -17.33% | $801.28M | +67.53% | 1.80% |
FDUS | -17.17% | - | - | 9.12% |
HEI | -16.95% | $33.72B | +18.53% | 0.09% |
WDI | -16.88% | - | - | 12.82% |
MFIC | -16.81% | - | - | 12.77% |
L | -16.76% | $18.12B | +12.15% | 0.29% |
PSTL | -16.59% | $317.00M | -2.75% | 7.05% |
K | -16.57% | $28.60B | +41.02% | 2.74% |
Current Value
$0.461 Year Return
Current Value
$0.461 Year Return